Dr. Michael Weiss

Orthopedics
Irise Spine And Joint
6782 W Sunrise Blvd, 
Plantation, FL 
Accepting New Patients
Irise Spine And Joint
6782 W Sunrise Blvd, 
Plantation, FL 

Overview

Michael Weiss is an Orthopedics provider practicing medicine in Plantation, Florida.

His clinical expertise encompasses Spinal Stenosis and Spondylolisthesis.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 10 clinical trials. Dr. Weiss is currently accepting new patients.

Specialties

Orthopedics

Licenses

Orthopaedic Surgery of the Spine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Irise Spine And Joint
6782 W Sunrise Blvd, Plantation, FL 33313

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Enrollment Status: Completed
Publish Date: February 18, 2026
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease
A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Drug
Study Drug: SHR-0302 JAK Inhibitor
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Enrollment Status: Completed
Publish Date: December 24, 2019
Intervention Type: Device
View 9 Less Clinical Trials

2 Total Publications

Patient Outcomes After Minimally Invasive Excision of Lumbar Synovial Cysts, With and Without a Spondylolisthesis, in an Ambulatory Care Center Setting.
Patient Outcomes After Minimally Invasive Excision of Lumbar Synovial Cysts, With and Without a Spondylolisthesis, in an Ambulatory Care Center Setting.
Journal: International journal of spine surgery
Published: July 14, 2022
Similar Doctors
Expertise in
18
conditions
Dr. Francis Hornicek
Orthopedics
Expertise in
18
conditions
Dr. Francis Hornicek
Orthopedics
Referral may be required

Office

1475 NW 12th Ave Fl 3, 
Miami, FL 
 (21.0 miles away)
305-243-3208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Francis Hornicek is an Orthopedics provider practicing medicine in Miami, Florida. Dr. Hornicek is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chordoma, Bone Tumor, Osteosarcoma, Osteotomy, and Bone Graft.

Expertise in
13
conditions
Dr. Matthew Dobbs
Orthopedics
Expertise in
13
conditions
Dr. Matthew Dobbs
Orthopedics
Referral may be required

Dobbs Clubfoot Center At Paley Orthopedic & Spine Institute

5325 Greenwood Ave Ste 203, 
West Palm Beach, FL 
 (46.5 miles away)
561-844-5255
Languages Spoken:
English
See accepted insurances

Matthew Dobbs is an Orthopedics provider practicing medicine in West Palm Beach, Florida. Dr. Dobbs is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Clubfoot, Flat Feet, Adolescent Idiopathic Scoliosis, Rhizotomy, and Tenotomy.

Expertise in
10
conditions
Dr. Elizabeth Ouellette
Orthopedics
Expertise in
10
conditions
Dr. Elizabeth Ouellette
Orthopedics
Referral may be required

Baptist Health Orthopedics | Plantation

1228 S Pine Island Rd Ste 310, 
Plantation, FL 
 (7.8 miles away)
954-392-1725
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elizabeth Ouellette is an Orthopedics provider practicing medicine in Plantation, Florida. Dr. Ouellette is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Carpal Tunnel Syndrome, Dupuytren Contracture, Rhizarthrosis, Ganglion Cyst, and Fasciotomy.

Frequently Asked Questions about Dr. Michael Weiss

Is Dr. Michael Weiss a top-rated expert for Spinal Stenosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Weiss is classified as an Experienced expert for Spinal Stenosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael Weiss specialize in?

While Dr. Michael Weiss is a Orthopedics, they have specific expertise in Spinal Stenosis, Spondylolisthesis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Orthopedics.

Does Dr. Michael Weiss participate in research or clinical trials?

Yes. Dr. Michael Weiss has published 2 articles and abstracts on conditions like Spinal Stenosis. You can view a list of Dr. Michael Weiss's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael Weiss accept my insurance?

Dr. Michael Weiss accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Weiss's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile